文献速递产科母胎医学

在71,986例普通风险和高风险妊娠中通过大小选择性胎儿DNA富集提高产前游离DNA筛查的性能

Improving the Performance of Prenatal Cell-Free DNA Screening Through Size-Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High-Risk Pregnancies.
PubMed 文献 · Prenat Diagn · 2025-03-15

本研究在71,986例妊娠中实施大小选择性游离胎儿DNA富集,比较富集前后普通风险与高风险人群的游离DNA筛查性能。富集后胎儿分数增至18.87±5.94,普通风险和高风险人群常见三体PPV分别增至88.46%和91.11%,CNV的PPV分别增至53.52%和66.67%,但SCA的PPV未改善。普通风险和高风险组的失败率分别降至0.01%和0.08%。

要点

  • 富集后普通风险和高风险人群常见三体PPV分别达88.46%和91.11%。
  • 富集后CNV的PPV在普通风险和高风险人群分别为53.52%和66.67%。
  • SCA的PPV未因游离胎儿DNA富集而改善。

核心结论

  • 游离胎儿DNA富集显著提高普通风险和高风险人群中常见三体和CNV的PPV,并具有提升游离DNA筛查临床应用效果的潜力。

研究设计与样本

  • 在71,986例妊娠中实施大小选择性游离胎儿DNA富集,收集21、18、13三体、性染色体异常(SCA)和拷贝数变异(CNV)的游离DNA筛查及随访结果,比较富集与否时普通风险和高风险妊娠的胎儿分数、阳性率和PPV。

主要发现

  • 富集后游离DNA的胎儿分数增至18.87±5.94。
  • 常见三体的总体PPV在普通风险和高风险人群分别增至88.46%和91.11%。
  • CNV的PPV在富集后普通风险和高风险人群分别增至53.52%和66.67%。
  • SCA的PPV未因游离胎儿DNA富集而提高。
  • 普通风险和高风险组的失败率分别降至0.01%和0.08%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of prenatal cell-free DNA (cfDNA) screening with and without the cell-free fetal DNA enrichment method in general-risk and high-risk pregnancies. METHODS: We performed a size-selective cell-free fetal DNA enrichment in 71,986 pregnancies. The cfDNA screening and follow-up results were collected for trisomies 21, 18, 13, fetal sex chromosome abnormalities (SCAs), and copy number variants (CNVs). The fetal fraction of cfDNA, positive rates, and positive predictive values (PPV) were compared between the general-risk and high-risk pregnancies with and without enrichment. RESULTS: With the cell-free fetal DNA enrichment, the fetal fraction of cfDNA increased to 18.87 ± 5.94. The overall PPVs for common trisomies increased to 88.46% and 91.11% in the general- and high-risk populations, respectively. For CNVs, the PPVs with enrichment increased to 53.52% and 66.67% in the general risk and high-risk populations, respectively. However, for SCAs, the PPV was not improved by cell-free fetal DNA enrichment. The failure rates in the general-risk and high-risk groups decreased to 0.01% and 0.08%. CONCLUSIONS: Cell-free fetal DNA enrichment significantly improves the PPVs of common trisomies and CNVs in general and high-risk populations. It has the potential for the clinical application effect of cell-free DNA screening.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Hu L, Wen L, Liu Y, et al. Improving the Performance of Prenatal Cell-Free DNA Screening Through Size-Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High-Risk Pregnancies. Prenat Diagn. 2025. PMID: 40088145. doi:10.1002/pd.6775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。